Q1 FY27 Results: Revenue Drops 56%, Auditor Flags Verification Gaps

Revenue DeclineEmphasis Of MatterResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹67.51

prior close

₹70.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-5.4% vs market

Non - Ferrous Metals peers, median of 19sector · industry level+0.4%-5.4% vs sector

On the reaction day the stock moved 5.4 pts less than Nifty Microcap 250 and 5.4 pts less than its Non - Ferrous Metals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.3

10m

+1.3

15m

+1.3

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.0+0.4-5.4+0.4-5.4

Next day

-9.7+0.5-10.3-0.3-9.5

-14.2+0.6-14.8-1.6-12.6

-18.5+0.7-19.2-0.8-17.7

-22.6+1.1-23.7-1.1-21.5

-26.5+0.5-27.0-1.2-25.2

-26.6+1.3-27.9+1.7-28.3

15d

-24.9+0.5-25.4-1.0-23.9

-11.5-0.8-10.7-3.2-8.4

-18.2-0.9-17.2-8.1-10.0

—————

UpDownMarket · Nifty Microcap 250Sector · Non - Ferrous Metals peers, median of 19Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mardia Samyoung Capillary Tubes reported Q1 FY27 revenue of Rs 2,683.91 lakhs, down 56% YoY from Rs 6,111.74 lakhs. Net profit fell to Rs 105.06 lakhs from Rs 147.2 lakhs, EPS Rs 0.13 vs Rs 0.17. Company converted warrants into equity shares worth Rs 15.82 crores. Auditor raised concerns over unverified physical stock, trade receivables and payables, end-use of warrant funds, and Rs 22.84 crores in interest-free advances.

Likely market impact

Sharp revenue decline and audit verification gaps may concern investors about financial reporting quality and use of converted warrant funds.